Clinical trial
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2…
NCT00395512 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00395512 |
|---|---|
| Title | Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus |
| Official title | A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of SYR-322 Plus Pioglitazone HCl (Actos®), SYR-322 Alone or Pioglitazone HCl Alone in Subjects With Type 2 Diabetes |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Alogliptin, Pioglitazone, Placebo |
| Enrollment | 655 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Nov 3, 2006 |
| Last update posted | Mar 27, 2013 |
| Countries | Argentina, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, Hungary, India, Israel, Latvia and 11 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: